was done. While the majority of the amputations in patients registered with GPs from these two PCTs occurred at Shropshire County and Telford and Wrekin NHS Trusts, a small number took place at other hospitals. Applying the same methodology adopted by Ahmed et al to our data yields results similar to those given in the letter [ Where this occurs, it will lead to an under-estimation of the scale of hospital use by patients with diabetes (rather than an over-estimation as suggested in the letter).
The potential limitations of data derived from hospital episode statistics (HES) are well recognised but, as argued in the paper [2] , we believe that these limitations are now much less of a concern than they used to be, partly because of the financial incentive for hospital trusts in today's NHS to identify all people with diabetes, particularly surgical patients, and partly because of the close correspondence between the incidences we derived, both in terms of actual numbers and of geographical variation, and those published by the National Diabetes Audit (NDA), which uses completely different sources and analyses amputations occurring over the preceding 5 years. We spelled out the care with which each set of data must be interpreted in our paper [2] .
The point about the weakness of assumptions deriving from the small numbers of amputations in each individual PCT is well made. Hitherto, the alternative to using data from the 151 PCTs in England has been limited to aggregations into the ten Strategic Health Authorities, but the use of very much bigger populations inevitably dampens the variation that can be documented. However, when the number of cases in the chosen areas is low it will be affected to a greater extent by the peaks and troughs that inevitably characterise the incidence of clinical events. In general, the use of 3 year moving means will help mitigate this effect.
And while we agree that data based on a national diabetes register (which is the eventual aim of the NDA) would be preferable, we do not agree that it is premature to compare PCTs in the way that we have done. The data must be interpreted with care but the demonstration of variation between PCTs is a wake-up call. The intention is not to point a finger of blame at individual clinical groups, but to trigger further work to determine why such apparent variation exists-both within countries and between them: work similar to that undertaken by Ahmed et al. We do, however, agree wholeheartedly about the danger of complacency that can be induced in areas in which a low reported incidence may be the result, at least in part, of poor coding practice. A similar sense of false security may also exist in conurbations in England that have a particularly high prevalence of Asians in their population. The main message to be derived from our work is that apparent variation between different health economies should remain under close scrutiny and reasons should be sought for its occurrence.
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